Basilea Pharmaceutica to get $1.25m license fee from Pfizer
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the
Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million government funding to expand its clinical
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
A new strain of monkeypox virus named as MPXV clade Ib, which originated in the Democratic Republic of the Congo recently, is behind
August 19, 2024: Alzheimer’s is the most common form of dementia, but there is no known cure for the disease yet, though medicines
HQ Team August 19, 2024: Herbs have been utilized for medicinal purposes for thousands of years. Herbal supplements, including well-known products like ashwagandha,
HQ Team August 17, 2024: A team of scientists led by McMaster University in Canada has found that cells lining the gut play
HQ Team August 17, 2024: A new study reveals that one in four patients suffering from brain injury show some cognitive function during
HQ Team August 15, 2024: Sweden confirmed its first case of the most virulent form of Mpox Thursday, a viral infection found in